Back to Search
Start Over
Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia
- Source :
-
Leukemia Research . Jul2012, Vol. 36 Issue 7, p817-825. 9p. - Publication Year :
- 2012
-
Abstract
- Abstract: Ensuring adherence to therapy is a challenge in chronic diseases, particularly in cancers such as chronic myeloid leukemia (CML), where there has been increased availability and use of oral formulations. A conceptual model of adherence was developed based on findings from a comprehensive literature review, to inform strategies for improving adherence to oral CML therapies. A complex interplay of factors (including clinical, psychological and behavioural) influence adherence to such therapies. Healthcare professionals have a key role in promoting and facilitating adherence and future strategies should place greater emphasis on understanding patient-level experiences in order to create personalized solutions. [Copyright &y& Elsevier]
Details
- Language :
- English
- ISSN :
- 01452126
- Volume :
- 36
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- Leukemia Research
- Publication Type :
- Academic Journal
- Accession number :
- 76159353
- Full Text :
- https://doi.org/10.1016/j.leukres.2012.01.021